shenzhen salubris pharmaceuticals co., ltd.-凯发官网首页
shenzhen salubris pharmaceuticals co., ltd.-凯发官网首页
join us
凯发·k8国际(中国)首页登录
home page
about us
profile
affiliates/subsidiaries
development history
quality management
contact us
legal statement
adverse reaction report
science and technology
r&d platform
r&d pipeline
therapeutic field
international business
apis
finished products
medical device
download product list
contact
news center
news & trends
public information
international business
r&d pipeline
drug pipeline
medical devices pipeline
drug pipeline
therapeutic field
project name
indications
pre-clinical
ind
phase i
phase ii
phase iii
nda
cardiovascular and related
sacubitril allisartan calcium (s086)
hypertension
sacubitril allisartan calcium (s086)
chronic heart failure
allisartan isoproxilamlodipine besylate tablets
hypertension
allisartan isoproxilindapamide sustained-release tablets
hypertension
enarodustat (sal0951)
renal anemia
sal0104 (fxia inhibitor)
thrombosis
sal007 (china)
chronic heart failure
sal007 (usa)
chronic heart failure
sal003 (anti-pcsk9)
hypercholesterolemia
orthopaedics
sal056 (long-acting teriparatide)
osteoporosis
sal001 (forteo biosimilar)
osteoporosis
sal023(biosimilar)
osteoporosis
metabolism
fotagliptin
diabetes
sal015(glp.fc fusion protein)
diabetes
sal0112
diabetes
oncology
sal008(bi-specific antibodyfusion protein)
tumor
others
sal0114
depressant
small molecule drugs
biological medicine
网站地图